[1]
“ Formulation, characterization and in vivo evaluation of novel edible dosage form containing nebivolol HCl ”, Braz. J. Pharm. Sci., vol. 52, no. 1, pp. 179–190, Mar. 2016, doi: 10.1590/S1984-82502016000100020.